Article Text

Download PDFPDF
Randomised controlled trial
Two weeks of rifaximin relieves global symptoms and bloating in people with IBS without constipation

Statistics from Altmetric.com

Footnotes

  • Competing interests BS has received grants from Takeda, Prometheus, Movetis. Advisor for Salix, Prometheus, Ironwood, Movetis, AstraZeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.